« FDA Approvals - Watson Pharma shares spike on removal of FDA plant ban | Main | FDA Completes Final Analysis of "Total Body Formula" and "Total »

Piramal Healthcare gets US FDA approval for Digwal API facility


Piramal Healthcare gets US FDA approval for Digwal API facility (PharmaBiz)
Piramal Healthcare (formerly known as Nicholas Piramal India Ltd) has received US FDA approval for its Digwal API facility in Andhra Pradesh. This facility is one of the ten facilities globally that caters to the custom manufacturing arm of the company.

FDA officials state cost to stop tainted drug imports (Baltimore Sun)
FDA officials state cost to stop tainted drug imports The government needs $225 million and a range of new powers to protect Americans from unsafe drug imports, federal health officials said yesterday under tough questioning by lawmakers investigating a contaminated blood thinner from China.

Worksoft(R) Certify(TM) Integrates IT Governance to Ensure Alignment and Collaboration with Regulatory Compliance (Centre Daily Times)
Worksoft, Inc., a leading provider of solutions that accelerate deployments of SAP(R) applications, today announced that its flagship solution Worksoft Certify, can bridge the chasm between the processes of Governance, Risk and Compliance (GRC) and the processes of Application Life Cycle Management.
 

©2006 FDA-News.com. All rights reserved.